Screening for drug-resistant Candida yeasts with chromogenic agar. - Wikidata - thesis-toulmin - TriplyDB

Screening for drug-resistant Candida yeasts with chromogenic agar.

Screening for drug-resistant Candida yeasts with chromogenic agar.

http://www.wikidata.org/entity/Q34009338

about

The future of fungal susceptibility testing.

P2860

Q38258833-66D67EC0-7F85-494C-8F8B-D51C889555C9

P2860

Screening for drug-resistant Candida yeasts with chromogenic agar.

http://www.wikidata.org/entity/Q34009338

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Screening for drug-resistant Candida yeasts with chromogenic agar.

@ast

Screening for drug-resistant Candida yeasts with chromogenic agar.

@en

Screening for drug-resistant Candida yeasts with chromogenic agar.

@nl

type

label

Screening for drug-resistant Candida yeasts with chromogenic agar.

@ast

Screening for drug-resistant Candida yeasts with chromogenic agar.

@en

Screening for drug-resistant Candida yeasts with chromogenic agar.

@nl

prefLabel

Screening for drug-resistant Candida yeasts with chromogenic agar.

@ast

Screening for drug-resistant Candida yeasts with chromogenic agar.

@en

Screening for drug-resistant Candida yeasts with chromogenic agar.

@nl

P1433

Q34009338-9910E8CC-8318-471A-B8F8-1B06E8BF8439

P1476

Q34009338-44936833-FF81-4920-B506-64B9DABD9F49

P2093

Q34009338-0D84E4F6-B594-47B1-8F5A-6663462C30EC

Q34009338-120CE12B-8DF9-4549-BEA4-7BA72360D3C2

Q34009338-2B284B73-74E3-4EA4-81F6-021CFDD93466

Q34009338-6EAC76D3-BAFA-41AC-9C9A-B03C97B3E8B1

Q34009338-85537C56-B20A-43B3-8E8D-22B63E38EDF2

Q34009338-8F9C2360-0844-4E99-AD97-B36158CC5ED9

Q34009338-A01A005B-A259-4A00-B77A-ABE673AA5181

Q34009338-BA938CEA-B898-409D-84D9-E66B1804D7A1

Q34009338-FCD4D88A-69AD-43BC-B12B-1C2872E2C18A

P2860

Q34009338-0A25AD22-5CF4-4926-A2F4-860D632F0FEB

Q34009338-35E940C5-1F33-4736-90CA-E31F9C2F3728

Q34009338-45F3D719-B035-4AA2-82A9-092C0937C8C8

Q34009338-62701A5E-2731-42F0-83EE-1108F6A91A6D

Q34009338-75B29325-2A60-4A94-B484-69DDB83453FE

Q34009338-78EEF226-369F-428B-90B4-B9BF9FE995CA

Q34009338-7C1770A5-2A51-491E-838C-6C157767FDFD

Q34009338-A0A60D3F-0C48-42BE-BAFA-DC03A5B01AD1

Q34009338-A5556F4A-62BB-472F-A25F-B887FC5C429E

Q34009338-CD93463B-6441-4C27-A674-C30BDEC43501

P304

Q34009338-0B0EF0FA-C87E-43AE-8071-35AB47EFC8D3

P31

Q34009338-F1F4F3D7-3671-4DF9-98ED-883F251CCCD8

P356

Q34009338-2B54F790-2D78-42EA-B113-D99E02DD6E6F

P433

Q34009338-407DCDEE-83D1-4AB4-8B2C-B80B640A1A1A

P478

Q34009338-E535421A-ED78-4F9F-A7AD-CE56EEAD1B12

P577

Q34009338-DC6AF47F-B730-4D1E-896B-129F8A64BE88

P5875

Q34009338-B46011F1-B5D9-4E1E-88A4-A8DAB6736102

P698

Q34009338-725776AF-38B6-45A9-AD0B-A817001AE087

P921

Q34009338-FDA6EC7F-E14B-41E6-A724-95D594D9BE07

P932

Q34009338-9A96AC5B-B9B9-44B9-9DD0-014A34191047

P356

13693780903514542

P1433

Medical Mycology

P1476

Screening for drug-resistant Candida yeasts with chromogenic agar.

@en

P2093

Annette W Fothergill

http://www.w3.org/2001/XMLSchema#string

Dora I McCarthy

http://www.w3.org/2001/XMLSchema#string

Erin Brockway

http://www.w3.org/2001/XMLSchema#string

Fadi P Haikal

http://www.w3.org/2001/XMLSchema#string

Joseph D Zimmerman

http://www.w3.org/2001/XMLSchema#string

Michael J Broker

http://www.w3.org/2001/XMLSchema#string

Spencer W Redding

http://www.w3.org/2001/XMLSchema#string

Thomas F Patterson

http://www.w3.org/2001/XMLSchema#string

William R Kirkpatrick

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro activities of anidulafungin against more than 2,500 clinical isolates of Candida spp., including 315 isolates resistant to fluconazole

Evaluation of Etest and disk diffusion methods compared with broth microdilution antifungal susceptibility testing of clinical isolates of Candida spp. against posaconazole.

Epidemiology of oropharyngeal Candida colonization and infection in patients receiving radiation for head and neck cancer.

Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints.

Comparative evaluation of Etest and sensititre yeastone panels against the Clinical and Laboratory Standards Institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents

Management of systemic fungal infections: alternatives to itraconazole.

Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005-2006

Simple method for detecting fluconazole-resistant yeasts with chromogenic agar.

Comparative evaluation of macrodilution and chromogenic agar screening for determining fluconazole susceptibility of Candida albicans.

Development of caspofungin resistance following prolonged therapy for invasive candidiasis secondary to Candida glabrata infection.

P304

807-816

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/13693780903514542

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

48

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41172416

http://www.w3.org/2001/XMLSchema#string

P698

20109095

http://www.w3.org/2001/XMLSchema#string

P921

P932

2907471

http://www.w3.org/2001/XMLSchema#string